Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for Rationale and Design of Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial): A Randomized Open-label Study

NCT04523649 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04523649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04523649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for Rationale and Design of Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial): A Randomized Open-label Study
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2022
Completion date
December 31, 2025
Enrollment
1,740 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, cardiovascular